GLOBUS MEDICAL INC — Director's Dealing 2012

Aug 31, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GLOBUS MEDICAL INC (GMED)
CIK: 0001237831
Period of Report: 2012-08-29

Reporting Person: LIPTAK ROBERT (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-08-29	Stock Option (Right to Buy Class A Common Stock)	$15.34	A	15300	Acquired	2022-08-29	Class A Common Stock (15300)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	7244201	Indirect

Footnotes

F1: Clarus Ventures I Management, L.P. ("Clarus I Management") is the sole general partner of Clarus Lifesciences I, L.P. and Clarus Ventures I, LLC ("Clarus I GPLLC") is the sole general partner of Clarus I Management. Mr. Liptak is a managing director of Clarus I GPLLC. As a managing director of Clarus I GPLLC, Mr. Liptak has shared voting and disposition power related to these shares and disclaims beneficial ownership of these shares.

F2: These options vest over a three-year period with one-twelfth (1/12) of the options granted vesting on December 31, 2012, and the balance of the options granted vesting ratably on a quarterly basis over the following 11 quarters.